BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 34341009)

  • 21. Fusion genes with ALK as recurrent partner in ependymoma-like gliomas: a new brain tumor entity?
    Olsen TK; Panagopoulos I; Meling TR; Micci F; Gorunova L; Thorsen J; Due-Tønnessen B; Scheie D; Lund-Iversen M; Krossnes B; Saxhaug C; Heim S; Brandal P
    Neuro Oncol; 2015 Oct; 17(10):1365-73. PubMed ID: 25795305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is the absolute value of O(6)-methylguanine-DNA methyltransferase gene messenger RNA a prognostic factor, and does it predict the results of treatment of glioblastoma with temozolomide?
    Tanaka S; Akimoto J; Narita Y; Oka H; Tashiro T
    J Neurosurg; 2014 Oct; 121(4):818-26. PubMed ID: 25105699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic and transcriptomic profiles of glioblastoma invasion revealed by comparisons between patients and corresponding orthotopic xenografts in mice.
    Cudalbu C; Bady P; Lai M; Xin L; Gusyatiner O; Hamou MF; Lepore M; Brouland JP; Daniel RT; Hottinger AF; Hegi ME
    Acta Neuropathol Commun; 2021 Aug; 9(1):133. PubMed ID: 34348785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrated genomic profiling identifies candidate genes implicated in glioma-genesis and a novel LEO1-SLC12A1 fusion gene.
    Bralten LB; Kloosterhof NK; Gravendeel LA; Sacchetti A; Duijm EJ; Kros JM; van den Bent MJ; Hoogenraad CC; Sillevis Smitt PA; French PJ
    Genes Chromosomes Cancer; 2010 Jun; 49(6):509-17. PubMed ID: 20196086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive genomic profiling of glioblastoma tumors, BTICs, and xenografts reveals stability and adaptation to growth environments.
    Shen Y; Grisdale CJ; Islam SA; Bose P; Lever J; Zhao EY; Grinshtein N; Ma Y; Mungall AJ; Moore RA; Lun X; Senger DL; Robbins SM; Wang AY; MacIsaac JL; Kobor MS; Luchman HA; Weiss S; Chan JA; Blough MD; Kaplan DR; Cairncross JG; Marra MA; Jones SJM
    Proc Natl Acad Sci U S A; 2019 Sep; 116(38):19098-19108. PubMed ID: 31471491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case study of a long-term glioblastoma survivor with unmethylated
    Jue TR; Olafson LR; Siddell AH; Rapkins RW; Ng B; Yin JXM; Lu VM; Chung SA; Whittaker SP; Davies M; Fairhall JM; Hovey EJ; McDonald KL
    Cold Spring Harb Mol Case Stud; 2019 Jun; 5(3):. PubMed ID: 31160353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extensive Leptomeningeal Intracranial and Spinal Metastases in a Patient with a Supratentorial Glioblastoma Multiforme, IDH-Wildtype.
    Schwartz C; Romagna A; Machegger L; Weiss L; Huemer F; Fastner G; Kleindienst W; Weis S; Greil R; Winkler PA
    World Neurosurg; 2018 Dec; 120():442-447. PubMed ID: 30253992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spatial transcriptome analysis reveals Notch pathway-associated prognostic markers in IDH1 wild-type glioblastoma involving the subventricular zone.
    Jungk C; Mock A; Exner J; Geisenberger C; Warta R; Capper D; Abdollahi A; Friauf S; Lahrmann B; Grabe N; Beckhove P; von Deimling A; Unterberg A; Herold-Mende C
    BMC Med; 2016 Oct; 14(1):170. PubMed ID: 27782828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ALK inhibitors, alectinib and ceritinib, induce ALK-independent and STAT3-dependent glioblastoma cell death.
    Kawauchi D; Takahashi M; Satomi K; Yamamuro S; Kobayashi T; Uchida E; Honda-Kitahara M; Narita Y; Iwadate Y; Ichimura K; Tomiyama A
    Cancer Sci; 2021 Jun; 112(6):2442-2453. PubMed ID: 33728771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptome analyses reveal molecular mechanisms underlying phenotypic differences among transcriptional subtypes of glioblastoma.
    Pan YB; Wang S; Yang B; Jiang Z; Lenahan C; Wang J; Zhang J; Shao A
    J Cell Mol Med; 2020 Apr; 24(7):3901-3916. PubMed ID: 32091665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spatiotemporal genomic architecture informs precision oncology in glioblastoma.
    Lee JK; Wang J; Sa JK; Ladewig E; Lee HO; Lee IH; Kang HJ; Rosenbloom DS; Camara PG; Liu Z; van Nieuwenhuizen P; Jung SW; Choi SW; Kim J; Chen A; Kim KT; Shin S; Seo YJ; Oh JM; Shin YJ; Park CK; Kong DS; Seol HJ; Blumberg A; Lee JI; Iavarone A; Park WY; Rabadan R; Nam DH
    Nat Genet; 2017 Apr; 49(4):594-599. PubMed ID: 28263318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of the methylation status of MGMT in different regions within glioblastoma multiforme.
    Hamilton MG; Roldán G; Magliocco A; McIntyre JB; Parney I; Easaw JC
    J Neurooncol; 2011 Apr; 102(2):255-60. PubMed ID: 20652362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive portrait of recurrent glioblastoma multiforme in molecular and clinical characteristics.
    Li R; Chen X; You Y; Wang X; Liu Y; Hu Q; Yan W
    Oncotarget; 2015 Oct; 6(31):30968-74. PubMed ID: 26427041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glioblastoma: pathology, molecular mechanisms and markers.
    Aldape K; Zadeh G; Mansouri S; Reifenberger G; von Deimling A
    Acta Neuropathol; 2015 Jun; 129(6):829-48. PubMed ID: 25943888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of novel human glioblastoma-specific transcripts by serial analysis of gene expression data mining.
    Su Y; Xiong J; Bing Z; Zeng X; Zhang Y; Fu X; Peng X
    Cancer Biomark; 2013; 13(5):367-75. PubMed ID: 24440977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MPC1 deletion is associated with poor prognosis and temozolomide resistance in glioblastoma.
    Chai Y; Wang C; Liu W; Fan Y; Zhang Y
    J Neurooncol; 2019 Sep; 144(2):293-301. PubMed ID: 31236818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic investigation of multicentric glioblastoma multiforme: case report.
    Schroeder B; Shah N; Rostad S; McCullough B; Aguedan B; Foltz G; Cobbs C
    J Neurosurg; 2016 May; 124(5):1353-8. PubMed ID: 26473785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a panel of genes as a prognostic biomarker for glioblastoma.
    Wang F; Zheng Z; Guan J; Qi D; Zhou S; Shen X; Wang F; Wenkert D; Kirmani B; Solouki T; Fonkem E; Wong ET; Huang JH; Wu E
    EBioMedicine; 2018 Nov; 37():68-77. PubMed ID: 30341039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRI to MGMT: predicting methylation status in glioblastoma patients using convolutional recurrent neural networks.
    Han L; Kamdar MR
    Pac Symp Biocomput; 2018; 23():331-342. PubMed ID: 29218894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laser interstitial thermal therapy for newly diagnosed and recurrent glioblastoma.
    Thomas JG; Rao G; Kew Y; Prabhu SS
    Neurosurg Focus; 2016 Oct; 41(4):E12. PubMed ID: 27690657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.